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Signal transduction pathways guided by cellular receptors commonly exhibit low-level constitutive signaling in a
continuous, ligand-independent manner. The dynamic equilibrium of positive and negative regulators establishes such
a tonic signal. Ligand-independent signaling by the precursors of mature antigen receptors regulates development of
B and T lymphocytes. Here we describe a basal signal that controls gene expression profiles in the Jurkat T cell line and
mouse thymocytes. Using DNA microarrays and Northern blots to analyze unstimulated cells, we demonstrate that
expression of a cluster of genes, including RAG-1 and RAG-2, is repressed by constitutive signals requiring the adapter
molecules LAT and SLP-76. This TCR-like pathway results in constitutive low-level activity of Erk and Abl kinases.
Inhibition of Abl by the drug STI-571 or inhibition of signaling events upstream of Erk increases RAG-1 expression. Our
data suggest that physiologic gene expression programs depend upon tonic activity of signaling pathways
independent of receptor ligation.
Introduction
Considerable evidence supports the notion that in most
signal transduction systems regulated by cellular receptors
some basal level of signaling occurs continuously in a ligand-
independent manner, although the flux through such systems
may vary considerably. The basal tone or the steady-state level
of signaling in unstimulated cells is the result of an
equilibrium of positive and negative regulators within a
signaling pathway. This dynamic equilibrium is often revealed
when the functions of negative regulators of signal trans-
duction are impaired. For instance, inactivation of tyrosine
phosphatase function by inhibitors (e.g., by pervanadate)
frequently leads to an increased level of tyrosine phosphor-
ylation of cellular proteins, in a ligand-independent manner.
Recent studies in the yeast mating pathway have shown that
inactivation of regulators of G-protein signaling (RGS
proteins) can induce constitutive activation of downstream
signaling pathways even in the absence of receptor expression
(Siekhaus and Drubin 2003). Thus, the balanced actions of
positive and negative regulators of signal transduction set the
steady-state equilibrium. Receptor stimulation then perturbs
the equilibrium state in various ways to initiate cellular
responses. The steady-state level of signaling in the unstimu-
lated state may itself have functional consequences, for
instance, to maintain certain differentiated cellular proper-
ties or functions.
In the immune system, signal transduction pathways that
are regulated by antigen receptors are functionally important
for the appropriate development of properly selected T and
B lymphocytes as well as in controlling responses to antigen
by more mature cells. Ligand-independent signaling by the
pre-T and pre-B cell antigen receptors (pre-TCR and pre-
BCR, respectively) promotes the developmental progression
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of immature cells (Irving et al. 1998; Saint-Ruf et al. 2000;
Fuentes-Panana and Monroe 2001; Aifantis et al. 2002).
Upregulation of receptor expression may account for the
unique property of these unligated receptors to initiate the
signaling events that are required for maturation to the next
stage. An alternative explanation for induction of signaling
events by unligated receptors may be receptor clustering and
localization to lipid rafts. However, unique cellular compart-
mentalization of the receptor does not seem to explain the
requirement for cell surface expression of the mature BCR
for B cell survival, as observed in a hapten-specific receptor
system (Lam et al. 1997). This suggests that basal signaling
tone by the unligated BCR that can interact, perhaps by
chance, with cellular machinery may be sufficient to send
signals downstream that are required for B cells’ survival. The
precise nature of the signaling events that set the basal
steady-state level of signaling at any stage of differentiation
has not been studied in detail. However, the mechanisms by
which the TCR and BCR initiate signaling in response to
ligand have been well studied. The mechanisms involved in
transmitting the ligand-occupied state of the receptor are
likely to also contribute to the basal state of signaling since
these same effectors must be regulated before and after
receptor ligation. The magnitude and qualitative properties
of the signals generated, however, are likely to differ
substantially.
The TCR consists of the antigen-binding TCRa and TCRb
chains associated with the signal-transducing subunits CD3c,
CD3d, CD3e, and TCRf chains (Weiss and Littman 1994). TCR
stimulation (with or without CD4 or CD8 coreceptors) results
in the activation of Lck and Fyn, Src protein tyrosine kinases
(PTKs) that phosphorylate immunoreceptor tyrosine-based
activation motifs (ITAMs) present in the cytoplasmic tail of
TCRf and CD3 chains. The Syk PTKs, Syk and ZAP-70, are
recruited to the doubly phosphorylated tyrosines in the ITAM
and are subsequently tyrosine-phosphorylated themselves,
resulting in their activation (Weiss and Littman 1994; Kane et
al. 2000). Activated Src and Syk family kinases phosphorylate
various substrates, including the adapter LAT (linker for
activation in T cells) (Zhang et al. 1998). LAT is palmitoylated,
a modification that ensures its proper localization and
function in the glycolipid-enriched microdomains (GEMs)
(Lin et al. 1999). Phosphorylation of multiple tyrosine
residues in LAT creates distinct docking sites for many
signaling proteins, including phospholipase Cc1 (PLCc1),
SLP-76 (via Gads), Grb2, Grap, Gads, the p85 regulatory
subunit of phosphoinositide 39-kinase (PI3K), Vav, and Cbl
(reviewed in Tomlinson et al. 2000)). A pivotal role for LAT in
TCR signaling was demonstrated in studies using Jurkat T
cells deficient in LAT, which display severely impaired PLCc1
phosphorylation, calcium influx, and MAP kinase (MAPK)
activation, as well as impaired activation of transcription
factors AP-1, NFAT, and NF-jB upon TCR engagement
(Finco et al. 1998). A similar, though less severe, phenotype
was observed in SLP-76-deficient Jurkat T cells (Yablonski et
al. 1998). These results point to a requirement for the LAT/
SLP-76 module to transmit a signal(s) initiated by engage-
ment of the TCR to the downstream calcium and MAPK
pathways.
The thymic developmental blocks observed in mice
deficient in LAT or SLP-76 highlight the physiologic
importance of the signaling events mediated by these
proteins (Clements et al. 1998; Pivniouk et al. 1998; Zhang
et al. 1999). Mice rendered deficient in these proteins display
an early block in thymocyte development at the CD44CD25þ
double-negative (DN) (CD4 and CD8) stage due to a defect
in ligand-independent pre-TCR signaling (see below). Sim-
ilarly, thymocytes of mice lacking Rag-1 or Rag-2 are arrested
at the same stage, thus linking the genes responsible for
recombination and subsequent expression of the TCR with
the downstream signaling pathways (Mombaerts et al. 1992;
Shinkai et al. 1992).
Physiological Rag (in this manuscript we refer to both Rag-1
and Rag-2 as Rag) expression is strictly regulated, allowing
sequential rearrangements of the TCRb and TCRa genes
(Schatz et al. 1992). Rag gene expression can first be detected
when DN thymocytes become positive for CD25 and start to
rearrange the TCRb locus. Successful b rearrangement results
in surface expression of the pre-TCR, made up of the b chain
heterodimerized with a surrogate for the a chain (pre-Ta) and
complexed with the signal transducing CD3 and f chains.
Low-level surface expression of the pre-TCR by itself can
signal independently of the extracellular portions of the
TCRb and pre-Ta chains leading to increased activities of
downstream signaling pathways (Irving et al. 1998). Perhaps
this reflects the unique localization of the pre-TCR receptor
to GEMs (Aifantis et al. 2002), although other studies suggest
that GEM localization may not be a unique property of the
pre-TCR compared to the abTCR on thymocytes (Haks et al.
2003). For the thymocyte, this results in increased survival,
proliferation, progression to the double-postive (DP) (CD4þ
and CD8þ) stage, and TCRb allelic exclusion. This transition is
at all times accompanied by termination of Rag gene
expression, although the exact mechanism is unclear (Nagao-
ka et al. 2000). It is apparent that such termination is as
important as the induction of Rag gene expression, as
evidenced by altered thymocyte development in mice with
transgenic, aberrant Rag expression (Wayne et al. 1994). DP
thymocytes undergo a second wave of Rag gene expression,
required to rearrange the newly accessible TCRa locus
(Wilson et al. 1994), but it remains unclear which signals
induce reexpression of Rag genes. Productive rearrangement
of the TCRa locus leads to expression of the mature abTCR
on the surface. In contrast to pre-TCR b-chain selection in
DN thymocytes, Rag expression and rearrangement in DP
cells are only terminated after appropriate ligation of the
TCR during positive selection by self-peptide and major
histocompatibility complex (MHC) molecules (Nagaoka et al.
2000). Positively selected thymocytes proceed to the single-
positive stage (SP) (CD4þ or CD8þ), the direct precursors of
peripheral T cells.
Rag-1 and Rag-2 are unusual genes in that they have
remained linked and conserved throughout evolution, are
orientated in opposite directions, and are exclusively coex-
pressed in lymphoid cells (Schatz et al. 1989, 1992; Oettinger
et al. 1990). Two crucial regulatory regions in the Rag-1 and
Rag-2 loci were mapped in studies of transgenic mice carrying
bacterial artificial chromosomes encompassing different
portions of the Rag locus (Yu et al. 1999). DN thymocytes of
these mice required 10 kb of genomic sequence 59 of Rag-2
essential for normal expression of both Rag-1 and Rag-2,
whereas DP cells needed an 110 kb region upstream of Rag-2
for both genes. Interestingly, Rag gene expression occurs in
two waves. This characteristic rules out transcriptional
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regulation by permanent, heritable silencing after the first
window of Rag gene expression (Fisher and Merkenschlager
2002). Instead, it suggests a requirement for transient
repression by uncharacterized signaling pathways until Rag
gene expression is no longer needed and the genes can be
heritably silenced, accompanied by locus translocation to
centromeric DNA, as has been described for SP thymocytes
(Brown et al. 1999).
Basal signaling events in DN and DP thymocytes could
contribute to the differentiated state of the thymocyte and to
the regulation of Rag gene expression. The exact nature of
basal signaling in thymocytes is unknown, but it is probably
mechanistically similar to that which is regulated by the pre-
TCR and mature TCR. In unstimulated Jurkat T cells, basal
signaling activities can be visualized, for instance, by
pervanadate treatment or expression of truncated signaling
molecules that block signal transduction. We used this model
cell line to initiate our studies to examine the potential
constitutive signaling pathways in thymocytes. We first
analyzed the basal signaling pathway that is downstream of
the TCR using the Jurkat T cell line and TCR signaling
pathway mutant clones, which were derived from wild-type
Jurkat cells. We hypothesized that these well-characterized
mutants should have perturbations in their basal signaling
machinery. We compared gene expression patterns in wild-
type Jurkat T cells with those in these somatic mutants. Our
identification of RAG genes as targets of a basal signaling
pathway defective in some Jurkat mutants led us to explore
the potential function of this pathway in regulating RAG gene
expression in Jurkat cells and in thymocytes, by using
chemical inhibitors to block basal signaling. We found that,
in both Jurkat cells and in thymocytes, constitutive signaling
represses expression of a group of genes that includes the
RAG genes. Normal RAG gene expression depends on the
adapter protein LAT, which transduces a signal to two
pathways that induce low-level kinase activity of Erk and Abl.
Results
Evidence for Transcriptional Regulation by Tonic Activity
of a TCR-Like Signaling Pathway in Unstimulated Jurkat T
Cells
The Jurkat T cell leukemic line E6–1 expresses high levels
of mature TCR and low levels of CD4, but no CD8 or MHC
class II. These cells therefore do not cross-present antigen or
respond to administration of superantigen alone (Fraser et al.
1992). In this cell line, phospho-TCRf can be trapped and
upregulated in resting cells that overexpress the tandem SH2
domains of ZAP-70 in the absence of TCR stimulation (Qian
et al. 1996). The tandem SH2 domains of ZAP-70 presumably
compete with endogenous phosphatases that oppose the
action of Lck and dephosphorylate TCRf under basal
conditions. This lends support to the existence of a
constitutive but tonically regulated signaling pathway in
unstimulated Jurkat cells. Therefore, we postulated that the
same tonic signaling pathway might regulate a gene expres-
sion program in Jurkat cells and that a similar pathway might
exist in thymocytes or T cells.
We employed a panel of Jurkat T cell mutants lacking
specific TCR signaling proteins to study the transcriptional
consequences of this constitutive signaling pathway, with the
notion that the loss of key components, even in unstimulated
cells, might have consequences on the expression of a set of
genes. Using DNA microarrays, we compared gene expression
profiles of Jurkat-derived T cell lines deficient for Lck
(J.CaM1) (Straus and Weiss 1992), LAT (J.CaM2) (Finco et al.
1998), SLP-76 (J14) (Yablonski et al. 1998), ZAP-70 (P116)
(Williams et al. 1998), and CD45 (J45) (Koretzky et al. 1991) to
those of wild-type Jurkat T cells. We set out to analyze
aberrant gene expression caused by the lack of constitutive
signaling in the mutant lines. Confirming original reports,
LAT and SLP-76 (LCP2) mRNA levels were reduced in J.CaM2
and J14 (Finco et al. 1998; Yablonski et al. 1998) (Figure 1A).
In addition, all mutant lines demonstrated many unique
alterations in expression levels of a large number of genes
compared to wild-type Jurkat cells, even though they are all
derived from the parental Jurkat T cell line. It is possible that
altered gene expression resulting from random mutations
caused by chemical or radiation mutagenesis, unrelated to the
TCR signaling defect, complicated this analysis (Figure 1A).
We reasoned that the effects of disrupting a low-level, basal
signal would be most evident in a cell line with an absolute
block in TCR signaling and thus initially focused on J.CaM2.
Signaling events like calcium mobilization or activation of
MAPKs are severely impaired in LAT-deficient J.CaM2 even
when the TCR is heavily cross-linked (Finco et al. 1998) (data
not shown). We mathematically isolated the differences in
gene expression profiles between J.CaM2 and Jurkat and
identified a large cluster of genes expressed at lower levels in
J.CaM2 than in wild-type Jurkat T cells (left three columns in
green in Figure 1B). This cluster encompassed many cell
surface markers, including CD18 (b2 integrin), CD62L (L-
selectin), CD28, and TCRa. We validated these observations
by fluorescence-activated cell sorting (FACS) analysis and
noticed that the expression levels of other cell surface
markers like CD2, CD5, and CD7 were also reduced. Stable
reconstitution of J.CaM2 with LAT cDNA (J.CaM2-LAT)
(Finco et al. 1998), however, did not result in reexpression
of these markers as analyzed by FACS or Northern blot
analysis (data not shown). Expression levels of two nuclear
proteins, TCF7 (Tcf-1) and BIN2, were also reduced in
J.CaM2, but again not restored in J.CaM2-LAT, as evidenced
by Northern blotting (data not shown). We concluded that the
reduced expression levels of these genes could not be
explained by a lack of LAT expression. Instead, one or more
additional key transcriptional regulators may be defective in
the J.CaM2 line.
LAT-deficient cells also displayed a distinct cluster of
genes, including RAG-1 and RAG-2, expressed at higher levels
than wild-type Jurkat (left three columns in red in Figure 1B).
These findings were shared with SLP-76-deficient cells (Figure
1A). The elevated expression levels of RAG-1 and RAG-2
particularly interested us since it has been well established
that induction of the TCR signaling pathway is able to
terminate Rag gene expression (Nagaoka et al. 2000). We
therefore focused on this cluster of ‘‘derepressed’’ genes
observed in the J.CaM2 cells. We hypothesized that normal
RAG gene expression in resting cells is held in check by a
basal signal that requires both LAT and SLP-76.
To test this hypothesis and to confirm the results obtained
in the DNA microarray experiments, we isolated RNA from
several cell lines and determined RAG-1 expression levels by
Northern blot analysis. Wild-type Jurkat T cells express very
low but detectable levels of RAG-1 mRNA (Figure 1C, lane 4).
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The RAG locus is thus accessible to transcription factors,
making this cell line a fortuitous model for our experiments.
RAG-1 expression was markedly increased in J.CaM2 and
more moderately in J14 cells compared to that in wild-type
Jurkat (Figure 1C). The reduced effect of missing SLP-76 in
J14 cells on RAG expression could reflect the leaky TCR-
signaling phenotype of this mutant (Yablonski et al. 1998).
Importantly, expression levels were reduced in both mutant
cell lines when the repective mutations were complemented
with cDNAs encoding full-length LAT (J.CaM2-LAT) (Finco et
al. 1998) or SLP-76 (J14–76-11) (Yablonski et al. 1998). The
elevated RAG-1 expression in the mutants was therefore not
an aberrant characteristic caused by accidental mutations at
other loci, but rather a result of the deficiency of the adapters
LAT or SLP-76. As on the microarray, RAG-1 expression
levels analyzed by Northern blot analysis were not increased
in J.CaM1 (data not shown). Despite the Lck deficiency,
J.CaM1-deficient cells flux calcium when the TCR is heavily
cross-linked or in response to anti-CD3 antibodies (Straus
and Weiss 1992). Expression of Fyn in these cells is a likely
explanation for this signal. In a similar fashion, a low signal
may be capable to control RAG-1 expression in J.CaM2 cells.
We also made use of mutant Jurkat lines to test whether
surface abTCR expression was required for normal RAG-1
expression, as observed in wild-type Jurkat cells. TCRa-
deficient (J.RT-T3.1) or TCRb-deficient (J.RT3-T3.5) Jurkat T
cells (Ohashi et al. 1985) were generated in a screen for
abTCR-negative cell lines (Weiss and Stobo 1984). We
repeated previously published FACS analyses and functional
experiments on these lines. The TCRa- and TCRb-deficient
Jurkat lines express very low, if any, CD3e on the surface, but
no abTCR (Weiss and Stobo 1984; data not shown). As a
result, these cells do not flux calcium, produce IL-2, or
demonstrate NFAT transcriptional activity in response to
TCR stimulation (Ohashi et al. 1985; data not shown). The
TCRa- or TCRb-deficient Jurkat T cells did not display
elevated RAG-1 expression levels such as we observed in LAT-
deficient cells (Figure 1D). Surface expression of the abTCR is
therefore dispensable for maintenance of normal levels of
RAG-1 transcripts. Importantly, these results imply that the
tonic signal regulating RAG gene expression is not generated
by (stimulation of) the extracellular portion of the abTCR,
but rather by an intrinsically active signaling pathway. At
least one of these mutants, JRT-T3.1, has been reported to
express surface TCRf (Ono et al. 1995); we can therefore not
completely exclude the possibility that signaling components
of the TCR play a role in regulating this pathway.
Requirement for LAT in Tonic Repression of RAG-1
Transcription Is Bypassed by Direct Activation of PKC or
MAPK Pathways
Rag-1 and Rag-2 are expressed in DP thymocytes and
turned off during subsequent thymic maturation. This
process can be mimicked in thymocytes in vitro by cross-
linking the TCR, which leads to activation of PLCc and
subsequent generation of the second messengers diacylglyc-
erol (DAG) and inositol trisphosphate (IP3) (Turka et al.
1991). The same effect is obtained when DAG and IP3
generation are replaced by stimulation with synthetic
analogues phorbol myristate acetate (PMA) and ionomycin
(Turka et al. 1991). PMA and ionomycin stimulation also
bypasses LAT and SLP-76 deficiencies in transcriptional
responses in the Jurkat line (Finco et al. 1998; Yablonski et al.
1998). Stimulation of J.CaM2 by PMA or another phorbol
ester, phorbol-12,13-dibutyrate (PDBu), resulted in complete
downregulation of the elevated RAG-1 transcripts within 12 h
(Figure 2A). Induction of a calcium flux by ionomycin,
however, did not substantially diminish RAG-1 gene expres-
sion in J.CaM2 cells (data not shown). PMA or PDBu
stimulation induced a similar decrease in J14 cells (data not
shown). The same kinetics of decreased RAG-1 mRNA levels
were observed when transcription was blocked in J.CaM2 cells
by actinomycin D, demonstrating the instability of RAG-1
mRNA (data not shown). In contrast, transcripts of TCRa
were induced following PMA stimulation of J.CaM2 (Figure
2A), as has been described for wild-type Jurkat T cells
(Lindsten et al. 1988). The reduction of RAG-1 levels by PMA
stimulation was still observed when protein synthesis was
blocked with cycloheximide (Figure 2B). The cycloheximide
and actinomycin D experiments suggest that signals through
the PKC/MAPK pathways are able to repress RAG-1 gene
transcription in a relatively direct fashion, leading to loss of
Figure 1. Gene Expression Analysis of Resting Jurkat T Cells and Derived Signaling Mutants
(A) Basal gene expression of wild-type Jurkat T cells compared to Lck-deficient J.CaM1, CD45 (PTPRC)-deficient J45, LAT-deficient J.CaM2, ZAP-
70-deficient P116, and SLP-76 (LCP2)-deficient J14 signaling mutants. High-quality data were analyzed using the Statistical Analysis of
Microarrays software package (Tusher et al. 2001). After selecting high-quality data, array elements that were 2.5-fold above or below the median
on at least two microarrays were included (337 cDNA elements). These elements are displayed in hierarchical cluster format where rows
represent genes and columns represent experimental samples. Colored pixels capture the magnitude of the response for any gene. Shades of red
and green represent fold above and fold below the median, respectively. Black pixels reflect the median and gray pixels represent missing data.
Data in 337 rows correspond to 321 unique cDNA clones, representing 269 unique genes. Jurkat T cells were analyzed in six individual samples
and each mutant cell line in triplicate, and the sample dendrogram was generated by hierarchically clustering the arrays using the elements
shown. To interactively explore the data, go to http://microarray-pubs.stanford.edu/cgi-bin/tonicsignal/fig1a/gx?n¼fig1a. Abbreviations: FYB, Fyn-
binding protein; SELL, CD62L.
(B) Basal gene expression differences between unstimulated LAT deficient (J.CaM2) and wild-type Jurkat T cells. Data presented in the 273 rows
correspond to 251 unique cDNA clones and represent the 193 unique genes most differentially expressed between the two lines that were
selected (false discovery rate, ,1%). Elements were further filtered for being at least 2-fold different between the lines and for technically
adequate measurements in at least five of six samples analyzed. These elements are displayed as in (A). Abbreviations: MAGEA-8, melanoma
antigen, family A, 8; MAGEA-11, melanoma antigen, family A, 11. To interactively explore the data, go to http://microarray-pubs.
stanford.edu/cgi-bin/tonicsignal/fig1b/gx?n¼fig1b.
(C) Northern blot analysis of RAG-1 gene expression in Jurkat, J.CaM2, J14, and cDNA-reconstituted cell lines J.CaM2-LAT and J14-76-11. RNA
levels are indicated by b-actin hybridization. All Northern blots presented in this study are representative examples of three independent
experiments, unless mentioned otherwise.
(D) Resting Jurkat, TCRa-deficient (J.RT-T3.1), TCRb-deficient (J.RT3-T3.5), and LAT-deficient (J.CaM2) cell lines were analyzed for RAG-1 and
b-actin mRNA expression by Northern blot analysis.
DOI: 10.1371/journal.pbio.0000053.g001
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detectable RAG-1 mRNA. The fact that RAG-1 expression is
elevated in these cells, but can be reduced by a PMA signal,
suggests that the LAT/SLP-76 module is essential for a
constitutive, suppressive signal that operates, in part, through
the downstream signaling pathways. The MAPK pathway can
also be activated through seven-transmembrane receptor
signaling (Crespo et al. 1994). In J.CaM2 cells, this can be
achieved by carbachol treatment of cells that stably express
the human muscarinic receptor (J.CaM2-HM1-1.1) (Gold-
smith et al. 1989). Carbachol stimulation decreased RAG-1
and increased TCRa expression to the same extent as
observed with PMA (Figure 2C). Thus, pharmacologic and
physiologic activation of the PKC and MAPK pathways can
lead to inhibition of RAG-1 gene expression.
Normal Expression of a Gene Cluster Including RAG-1 and
RAG-2 Relies on a Signaling Competent LAT Molecule
We next examined whether signaling via LAT is essential
for the tonic suppression of RAG-1 expression. Phosphor-
ylation of conserved tyrosines in LAT (Figure 3A) is required
for the recruitment of downstream signaling effectors and
adaptors. It is technically very difficult to detect basally
phosphorylated LAT in resting cells since the antibody that
immunoprecipitates LAT recognizes phosphorylated LAT
very poorly (data not shown). However, we have previously
demonstrated that these phosphorylated tyrosine residues in
LAT can be substrates for the phosphatase CD148. Doxycy-
clin-inducible expression of CD148 in Jurkat T cells rather
selectively inhibits TCR-stimulated phosphorylation of LAT
and PLCc1; the latter effect may be secondary to the effect on
LAT (Baker et al. 2001). Induction of CD148 expression for 1,
3, or 7 d resulted in increasingly high RAG-1 levels, suggesting
that basal phosphorylation of LAT in unstimulated cells is
crucial for proper RAG-1 expression (Figure 3B). To further
address the importance of signaling via LAT, we generated
two new LAT mutant J.CaM2 cell lines. The first (J.CaM2-
LATallF) stably expresses normal levels of a LAT molecule
with all tyrosine residues replaced by phenylalanine residues.
The second (J.CaM2-LATCtoS) stably expresses a LAT
molecule in which sites for palmitoylation, cysteines 26 and
29, were both replaced by serine residues, displacing LAT
from localization to the GEMs (data not shown). Both cell
lines demonstrated the same impaired TCR-induced phos-
phorylation of Erk as we had previously observed in transient
assays (Lin et al. 1999; Lin and Weiss 2001). We used DNA
microarrays to compare global gene expression patterns in
Jurkat, J.CaM2, J.CaM2 reconstituted with wild-type LAT
(J.CaM2-LAT), J.CaM2-LATallF, and J.CaM2-LATCtoS cells.
These samples were also compared to J.CaM2 treated with
dimethyl sulphoxide (DMSO) as a control, J.CaM2 stimulated
with PMA that bypasses the requirement for LAT, and Jurkat
treated with the Src kinase inhibitor PP2. Figure 3C shows the
relative expression level of RAG-1 and RAG-2 in the different
samples compared to expression in Jurkat control cells
(expression ¼ 1). Expression of both RAG genes was elevated
in the absence of the adapter LAT and reduced in J.CaM2
reconstituted with wild-type LAT cDNA (Figure 3Ca–c). By
contrast, reconstitution with a signaling-defective LAT
molecule without tyrosine residues, and thus without docking
sites for other signaling proteins, did not result in a reduction
of RAG gene expression (Figure 3Cd). Reconstitution with a
LAT molecule that does not get palmitoylated resulted only
in partial reduction, suggesting that there is a partial,
constitutive signal generated by LAT molecules independent
of GEM localization (Figure 3Ce). These results clearly
indicate that proper localization and signaling through the
adapter LAT are required for normal suppression of RAG
gene expression in resting cells. Src and Syk family kinases
initiate signaling events upstream of LAT, leading to its
tyrosine phosphorylation. Since a potent and selective Syk
kinase inhibitor is not available, we used the Src kinase
selective inhibitor PP2 to inhibit Lck and Fyn function in
Jurkat cells. Addition of a related inhibitor, PP1, has been
reported to displace ZAP-70 from the cortical membrane of
Jurkat T cells (Huby et al. 1998), presumably resulting in
reduced phosphorylation of LAT. Treatment of unstimulated
Figure 2. Stimuli Bypassing LAT Deficiency in J.CaM2 Reduce Elevated
RAG-1 Expression
(A) LAT-deficient J.CaM2 cells were stimulated with PMA or PDBu
and analyzed for RAG-1 mRNA expression by Northern blot analysis.
In (A), (B), and (C), the same blot was hybridized with a fragment
encoding the constant region of TCRa and with b-actin to control for
stimulation and loading.
(B) Analysis of PMA-induced reduction of RAG-1 expression levels in
absence of protein synthesis blocked by cycloheximide treatment of
J.CaM2 cells. Control hybridizations were carried out by hybrid-
ization with the constant region of TCRa and with b-actin.
(C) Analysis of RAG-1 transcripts in J.CaM2-HM1-1.1 cells stimulated
for various time intervals with carbachol to trigger the human
muscarinic (HM) receptor subtype I on the surface of these cells.
DOI: 10.1371/journal.pbio.0000053.g002
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Jurkat cells with PP2 increased expression of RAG-1 and RAG-
2 to a level similar to that in J.CaM2 cells, suggesting that
basal Lck and/or Fyn kinase activity is required for
constitutive repression of these genes (Figure 3Ch).
To investigate whether constitutive signaling through LAT
controls other genes in addition to RAG-1 and RAG-2, we
plotted the expression profiles of genes whose expression was
elevated in J.CaM2 relative to Jurkat cells and diminished by
restoration of LAT function in J.CaM2-LAT (Figure 3D).
Roughly 20 genes demonstrated such an expression profile.
As for the RAG genes, elevated levels of some but not of all of
these genes could be reduced by PMA stimulation of J.CaM2
or induced by PP2 treatment of wild-type Jurkat. Although at
this moment these genes have no obvious function in
lymphocyte biology or gene rearrangement, these data
suggest that expression patterns of several other genes can
be influenced by basal signaling through components of the
TCR signaling pathway in resting cells. It will be interesting to
investigate what role this group of genes may play in T cell
maturation.
Chemical Inhibitors Map the Tonic Suppression of RAG
Gene Expression to a TCR-Like Signaling Pathway
To further trace specific molecular components of this
tonic signaling pathway, we treated Jurkat cells for 24 h with
chemical inhibitors to various TCR-regulatable signaling
molecules. Resting Jurkat T cells were incubated with the
following inhibitors (molecular target indicated in paren-
thesis): PP2 (Src kinases), D609 (PLCc), Ro-318220 (novel PKC
family members), LY294002 (PI3K), PD98059 (MEK-1), U-
0126 (MEK-1 and MEK-2), FK506 (calcineurin), and DMSO
(vehicle control) (see Figure 4A). Addition of DMSO did not
alter the RAG-1 expression level. Inhibition of many of these
signaling molecules in wild-type Jurkat T cells induced
marked increases in RAG-1 gene expression (Figure 4A). All
these inhibitors except LY294002 yielded an approximately
4-fold induction of expression. The effects of the inhibitors
shown were specific since no change in RAG-1 expression was
observed when Jurkat cells were treated with inhibitors
specific for protein kinase A (PKA) (H89) and the mammalian
target of rapamycin (mTOR) (rapamycin) (data not shown).
Jurkat T cells are deficient for the phosphatases PTEN (39-
phosphatase and tensin homolog deleted on chromosome 10)
and SHIP (SH2-containing inositol polyphosphate 59-phos-
phatase) (Astoul et al. 2001). As a result, there is more active
inositol phospholipid signaling in Jurkat T cells, and PI3K
inhibitors elicit little effect. Induction of PTEN expression
using a doxycyclin-inducible expression system (Xu et al.
2002) produced no appreciable change in basal RAG-1
expression. Subsequent treatment of the PTEN-expressing
cell with LY294002, however, led to a level of induction of
RAG-1 expression similar to that observed with the other
inhibitors (Figure 4B). This would suggest that the high basal
level of phosphatidylinositol 3,4,5-trisphosphate (PIP3) in
Jurkat cells is not responsible for RAG-1 gene repression and
that the LY294002 could not modulate the levels of PIP3 in
Figure 3. Proper Expression of RAG-1 and RAG-2 Requires a Signaling-
Competent LAT Molecule
(A) Graphic representation of human LAT. Conserved tyrosine
residues in mammals are numbered 1 through 9, with the
corresponding amino acid numbering below. Cysteine residues 26
and 29 are required for palmitoylation. Adapted from Lin and Weiss
(2001).
(B) RAG-1 expression by Northern blotting in Jurkat T cells induced
to express the phosphatase CD148 for increasing periods of time.
(C) RAG-1 and RAG-2 expression by DNA array analysis. Expression
of the two genes was set at 1 in wild-type Jurkat cells and compared to
expression in J.CaM2 cells, in J.CaM2 reconstituted with wild-type
LAT (J.CaM2-LAT), or with signaling-mutant LAT molecules (J.CaM2-
LATallF and J.CaM2-LATCtoS). In addition, expression profiles were
compared to J.CaM2 treated with DMSO, J.CaM2 stimulated with
PMA (25 ng/ml for 24 h), and Jurkat cells incubated with PP2 (20lM
for 24 h).
(D) Expression profiles of genes with increased expression in J.CaM2
and a similar expression behavior as RAG-1 and RAG-2. Abbrevia-
tions: ABCB10, ATP-binding cassette, subfamily B, member 10; DTR,
diphteria toxin receptor; 1309069, similar to Rattus norvegicus nuclear-
encoded mitochandrial elongation factor G; SCN2A2, sodium
channel, voltage-gated, type II, a2 polypeptide; 2108230, unknown
human expressed sequence tag.
DOI: 10.1371/journal.pbio.0000053.g003
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Figure 4. Chemical Inhibitors Map the Constitutive Signal to a TCR-Like Pathway
(A) Northern blot analysis for RAG-1 expression in Jurkat T cells treated with the indicated inhibitors. Cells were incubated for 24 h prior to
RNA isolation. The relative expression level of RAG-1 was calculated from three independent experiments, and the mean expression and
standard deviation (SD) are indicated.
(B) Northern blot analysis for RAG-1 mRNA in Jurkat expressing the phosphatase PTEN treated with indicated inhibitors. (B) and (D) are
representative of two independent experiments.
(C) Basal signaling was blocked in wild-type thymocytes by treating with the indicated inhibitors for 20 h. CD4 and CD8 FACS profiles of
thymocytes were determined and expression of Rag-1 and b-actin was analyzed by Northern blotting.
(D) Northern blot analysis for Rag-1 expression in b2M//MHCII/ thymocytes treated for 20 h with the enzyme inhibitors.
DOI: 10.1371/journal.pbio.0000053.g004
PLoS Biology | http://biology.plosjournals.org Volume 1 | Issue 2 | Page 278
Tonic Erk and Abl Signals Repress RAG Expression
PTEN-deficient Jurkat cells, consistent with our previous
findings (Kane et al. 2002).
The effects of selective inhibitors, together with the results
of our previous experiments with mutant cell lines, point to a
tonic signaling pathway that closely resembles a TCR-
inducible pathway, with Src family kinase activity as the most
upstream component and MAPK as the most downstream
component regulating RAG-1 and RAG-2 expression in Jurkat
cells (for a model, see Figure 8). The same inhibitors yielded
very similar results in two mouse thymocyte cell lines, SCB29
and DPK (data not shown). The SCB29 cell line is derived
from a Scid mouse and expresses a pre-TCR (Groettrup et al.
1992). DPK is a CD4þCD8þ thymocyte line expressing a
transgene-encoded TCR (Kaye and Ellenberger 1992). Since
TCR signaling has been studied in great detail in Jurkat T
cells, we proceeded to use this model for our experiments and
verified our results in primary thymocytes.
A Similar Tonic Signaling Mechanism Represses Rag-1
Expression in Thymocytes of Wild-Type and
b2M//MHCII/ Mice
We noticed that primary murine thymocytes were more
sensitive to apoptosis induced by prolonged exposure to
chemical inhibitors. Nevertheless, we were able to determine
the effects of the signaling inhibitors on Rag-1 expression in
wild-type thymocytes by adding a general caspase inhibitor
(Z-DEVD-FMK) to our incubations in order to block
apoptosis. Addition of Z-DEVD-FMK by itself had no effect
on Rag-1 gene expression, but did improve survival without
affecting the relative proportions of the different thymocyte
subsets (determined by CD4, CD8, CD25, and CD44 staining;
data not shown). As observed in cell lines, inhibition of
components of the downstream TCR signaling pathway in
total thymocytes significantly increased Rag-1 gene expres-
sion (Figure 4C). The inhibitors delineated the same pathway
as in the Jurkat T cell and the thymocyte cell lines, including
Src kinases, PLCc1, PKC, PI3K, MEK-1, and calcineurin. The
magnitude of induced Rag-1 expression was more moderate
in thymocytes than the level observed in our model cell line.
The fact that thymocytes in the process of receptor
rearrangement already express Rag-1 may account for the
smaller induction over the existing level. We therefore
treated thymocytes from TCR transgenic OT-I mice with
inhibitors in the same manner. OT-I transgenic mice have a
thymus containing substantial numbers of DP thymocytes. In
absence of the peptide from chicken ovalbumin, these DP
thymocytes are positively selected on self-antigens and
effectively downregulate Rag expression (McGargill et al.
2000). As a result, the level of Rag-1 expression in thymocytes
of these animals is lower than that in wild-type littermate
thymi (Figure 5C, lanes 1 and 3). Treatment of OT-1
thymocytes with PP2 or U-0126 led to a strong induction in
Rag-1 expression, comparable to the effects observed in
Jurkat T cells (Figure 5C). These data argue that detection of
constitutive Rag repression in wild-type thymocytes is
hindered by normal Rag expression during rearrangement.
To eliminate the possibility that we were studying
inhibition of a signal induced by an MHC–peptide inter-
action with the TCR on the surface of the thymocyte, we
repeated the same experiment in b2M//MHCII/ thymo-
cytes (Grusby et al. 1993), which cannot encounter MHC–
peptide interactions and as a result are blocked at the DP
stage. The pattern of effects of the inhibitors on Rag-1 gene
expression in these mutant thymocytes was very similar to
that observed in the wild-type thymocytes (see Figure 4D).
The signal repressing Rag-1 gene expression is thus not
initiated by MHC–peptide stimulation, but instead appears to
be transmitted through a basal signaling pathway that
resembles the TCR-inducible signaling pathway. We utilized
the same panel of inhibitors to determine whether the same
constitutive repression of Rag-1 expression occurs in periph-
eral T cells. To prevent stimulation by antibody binding,
these cells were purified from lymph node and spleen
through negative selection of other cell populations. In
several independent experiments, we did not observe an
increase in Rag-1 expression in the inhibitor-treated periph-
eral T cells (data not shown).
Parallel Signaling Pathways Dependent on LAT Maintain
Basal Phosphorylation of Erk and Abl Kinases
The inhibitor studies suggest that a constitutive signaling
pathway may use components very similar to those involved
in conventional TCR signaling triggered upon receptor
ligation. We wanted to confirm and identify the downstream
effector molecules that transduce the repressive signal. The
MAPK pathway was clearly implicated; however, recent
studies suggested that Abl kinase activity might also be
involved.
Human c-Abl and its homologue Abl-related gene (Arg) are
nonreceptor tyrosine kinases with structural homology to Src
kinases (reviewed in Van Etten 1999). Kinase activity of c-Abl
in normal cells is suppressed by autoinhibition, depending on
80 N-terminal residues that are lost in translocations leading
to BCR–Abl fusion proteins and development of chronic
myelogenous leukemia (Pluk et al. 2002). The Abl inhibitor
STI-571/Gleevec/Imatinib (STI-571) recognizes c-Abl and Arg
but not Src, displaces ATP from Abl, and traps the kinase in
an inactive conformation (Schindler et al. 2000). STI-571 has
also been reported to inhibit the receptor tyrosine kinases c-
Kit and platelet-derived growth factor (PDGF) receptor at
higher doses (Schindler et al. 2000). Activation of c-Abl
requires the Src family kinases (Plattner et al. 1999). Abl
kinases have been linked to regulation of RAG gene
expression in studies of pre-B cells transformed by temper-
ature-sensitive mutants of the Abelson virus (Chen et al.
1994). Very recently, Muljo and Schlissel (2003) demonstrated
that treatment of Abelson virus-transformed pro-B cell lines
expressing active v-Abl with STI-571 activated transcription
of Rag-1 and Rag-2. Jurkat T cells express moderate levels of c-
Abl and low levels of Arg kinases, but are negative for c-Kit
and PDGF receptor (Taylor et al. 2001; Bianchi et al. 2002;
data not shown).
These findings prompted us to examine whether Abl
kinases might play a role in constitutive repression of RAG
genes. Indeed, inhibition of Abl kinase activity by STI-571 in
Jurkat T cells induced RAG-1 expression to a level similar to
that induced by the inhibitors PP2 and Ro-318220 (Figure
5A). Similarly, STI-571 induced elevated levels of Rag-1 in
wild-type thymocytes (Figure 5B). This effect was more
pronounced in TCR transgenic OT-1 thymocytes (Figure
5C). Abl has been reported to induce MAPK signaling in
response to stress (Kharbanda et al. 1995). To address
whether STI-571 functions to elevate RAG-1 expression
indirectly by reducing a MAPK signal or whether there is a
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distinct Abl pathway, we carefully analyzed the specific
phosphorylation status of Erk and Abl. Specific phosphor-
ylation on threonine 202/tyrosine 204 residues reflects the
kinase activities of Erk-1 and Erk-2. Active Abl is phosphory-
lated on tyrosine and serine residues (Pluk et al. 2002).
Phosphorylation of tyrosine 245 and tyrosine 412 in c-Abl are
crucial regulatory events required for its kinase activity
(Brasher and Van Etten 2000). Phosphorylation of tyrosine
245 reflects disruption of the inactive conformation and can
be detected with a phosphorylation-specific antibody.
In radioimmunoprecipitation assay (RIPA) lysates of rest-
ing J.CaM2 cells, we consistently observed an absence of basal
phosphorylated Erk-1 and Erk-2 proteins, signals that were
easily detected in Jurkat or J.CaM2-LAT (Figure 5D). Induced
expression of the phosphatase CD148 for 7 d also ablated this
constitutive phospho-Erk signal (Figure 5D, lane 5). Expres-
sion levels of c-Abl and the Erk-1 and Erk-2 kinases were
equal in all samples (upper and lower panels of Figure 5D).
Treatment of wild-type Jurkat T cells with chemical
inhibitors of signaling components revealed that inhibition
of Src family kinases, PLCc, PKC, MEK-1 and MEK-2, and
calcineurin (using PP2, D609, Ro-318220, U-0126, and FK506,
respectively) efficiently decreased the amount of phosphory-
lated Erk-1 and Erk-2, the reciprocal effect of that on RAG-1
expression (Figure 5E). Inhibition of calcineurin has been
reported to induce expression of the MAPK phosphatase 1
and inhibit Erk signaling in neuronal cells (Zawadzka and
Kaminska 2003). A similar mechanism may account for these
effects on Jurkat T cells and thymocytes. As seen for other
assays, the PI3K inhibitor LY294002 only has limited effect on
phospho-Erk-1 and phospho-Erk-2 levels in Jurkat T cells. To
our surprise, treatment with STI-571 only slightly decreased
phospho-Erk (Figure 5E, lane 8), raising the possibility that
Abl and Erk kinases may act in separate, basally active
pathways to repress RAG-1 expression.
To resolve this question, we analyzed these low-level,
constitutive phospho-c-Abl and phospho-Erk signals by
intracellular FACS staining (we were unable to use the site-
specific phospho-Y245 for c-Abl in Western blot analysis; data
not shown). Panels I–III of Figure 6A demonstrate the
feasibility of this approach. PMA stimulation of Jurkat T
cells for 10 min resulted in 6-fold induction of phospho-Erk
signal compared to unstimulated Jurkat (arbitrarily set at 100
in the accompanying bar graph of Figure 6A, panel I). As
shown in the same panel, 24-h administration of a MEK-1 and
MEK-2 inhibitor (U-0126) effectively blunted the phospho-
Erk response, whereas the c-Abl inhibitor had a detectable
but consistently smaller effect. The STI-571 inhibitor was,
however, very potent in blocking the phospho-Abl signal in
K562 cells, which reflects the kinase activity of BCR–Abl in
this cell line (Figure 6A, panel II). Similar to the basal activity
of the Erk kinases (Figure 6A, panel IV), phosphorylation of
tyrosine 245 in Abl was consistently reduced in unstimulated
J.CaM2 cells, resulting in a fluorescence signal not signifi-
cantly above isotype control (Figure 6A, panels V and VI). The
phospho-Abl signal observed in Jurkat T cells probably
reflects both phosphorylated c-Abl and phosphorylated Arg
since the two kinases are highly conserved in the tyrosine 245
region. Importantly, phospho-Abl levels were restored in the
J.CaM2-LAT line, pointing to an essential role for LAT in Abl
phosphorylation (Figure 6A, panel V; Figure 6B). The
reduction of c-Abl-specific phosphorylation in J.CaM2 cells
was confirmed by c-Abl immunoprecipitations followed by
total phosphotyrosine immunoblotting and was restored in
J.CaM2 cells complemented with LAT cDNA (Figure 6B).
Induced expression of the phosphatase CD148 for 7 d also
ablated this constitutive phospho-c-Abl signal (right panel in
Figure 6B).
Figure 5. Erk and Abl Kinases Transduce Repressive Signals That Control
RAG Gene Expression
(A) Northern blot analysis for RAG-1 gene expression in STI-571-
treated Jurkat T cells and comparison to PP2- or Ro-318220-treated
samples.
(B) Wild-type thymocytes were treated with the indicated inhibitors
for 20 h and analyzed for Rag-1 expression.
(C) Northern blot analysis of Rag-1 expression in inhibitor-treated
TCR transgenic OT-I thymocytes or wild-type thymocytes of
littermate controls. The relative expression level of Rag-1 was
calculated from two independent experiments, and the mean
expression and standard deviation (SD) are indicated.
(D) Western blot analysis using RIPA lysates of the indicated cell lines.
Protein levels of phosphorylated Erk-1 and Erk-2, Erk-1 and Erk-2,
and c-Abl were determined in 43 106 resting cells per sample.
(E) Analysis of phospho-Erk-1 and Erk-2 levels in Jurkat T cells
treated for 24 h with the indicated inhibitors prior to RIPA lysis.
Equal loading is indicated by Erk-1 and Erk-2 levels determined by
stripping and reprobing the same blot.
DOI: 10.1371/journal.pbio.0000053.g005
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Figure 6. LAT Is Required for Two Largely
Separate Pathways Marked by Constitutive
Phosphorylation of Erk and Abl Kinases
(A) Intracellular FACS staining for phos-
pho-Erk (I and IV), phospho-Abl (II and
V), and isotype control (III and VI) in the
indicated cell lines. Histograms are an
example of a representative experiment.
The accompanying bar graphs are de-
picted in the same color-coding and
represent the mean levels of fluores-
cence and standard deviation of three
independent assays for all experiments.
Mean levels of phosphoproteins meas-
ured by fluorescence in a resting Jurkat
population were arbitrarily set at 100,
and the mean fluorescence of the isotype
control samples is indicated by the
dotted line as a point of reference.
Specifics are mentioned in the text.
(B) Analysis of tyrosine phosphorylation
levels of c-Abl in the indicated cell
samples. c-Abl or control immunoperci-
pitations were immunoblotted for total
tyrosine phosphorylation by 4G10. The
same blot was stripped and reprobed for
c-Abl. Doxycyclin was administered for 7
d to induce CD148 expression.
(C) Resting Jurkat T cells were treated
with the indicated inhibitors for 24 h,
and intracellular FACS staining for
phospho-Abl and isotype control was
compared to that detected in vehicle-
treated Jurkat cells and the J.CaM2 line.
Bar graphs (representing three experi-
ments) display the four conditions de-
picted in the histograms as well as three
additional samples.
DOI: 10.1371/journal.pbio.0000053.g006
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The signals that elicit Abl phosphorylation were limited to
Src and Abl kinases since blockade of PLCc, MEK-1 and MEK-
2, or calcineurin activity had no effect on the phosphor-
ylation status of tyrosine 245 (Figure 6C). PP2 and STI-571
reduced the phospho-Abl level to that observed in J.CaM2,
virtually equal to isotype control staining. It should be noted
that PP2 has recently been reported to inhibit to some extent
c-Kit and BCR–Abl (Tatton et al. 2003). Therefore, the PP2
effect may be the combined result of blocking Src family
kinases and direct inhibition of Abl kinases. Together, these
findings suggest that constitutive activity of Abl represses
RAG gene expression, requires the presence of LAT, and is
blocked by Src and Abl kinase inhibitors, but is unaffected by
Erk activity.
Both Erk and Abl Kinases Repress RAG-1 Expression and
Require Phosphorylation of Tyrosine 132 in LAT
The unaltered phosphorylation status of Abl in U-0126-
treated cells suggested that the MEK–Erk pathway does not
contribute to basal Abl activity in our model. To further test
this, we elevated the basal MAPK signal in Jurkat T cells by
addition of 5 ng/ml PMA for 24 h. This treatment induced a
higher level of phospho-Erk that is largely abrogated by U-
0126, but not by PP2 (left panel of Figure 7A). By contrast, low
amounts of PMA did not induce phosphorylation of Abl
kinases (middle panel of Figure 7A). Therefore, whereas
inhibition of Abl has modest effects on Erk phosphorylation,
Erk activity does not enhance phosphorylation of tyrosine
245 in Abl. These observations further support the notion
that Abl and Erk operate independently to regulate the
expression of RAG-1. This notion is illustrated by the additive
effects of STI-571 and U-0126 in inducing RAG-1 expression
(Figure 7B). Moreover, it appears that the regulatory roles of
both kinases in this pathway depend on LAT. Addition of
STI-571, U-0126, or a combination of these inhibitors, or
even targeting Src family kinases upstream of Abl and Erk,
did not result in a hyperinduction of RAG-1 in the J.CaM2
line (Figure 7C).
Finally, the results above demonstrated that the roles of Erk
and Abl kinases in controlling RAG-1 gene expression are
largely parallel rather than sequential. MAPK activation by
TCR stimulation has been known to rely on LAT (Finco et al.
1998; Zhang et al. 1999). How does LAT transduce a unique
signal to Abl? To study a possible LAT–Abl connection, we
made use of a panel of J.CaM2 cell lines reconstituted with
LAT molecules that carry point mutations of tyrosine
residues (see Figure 3A). We and others have previously
demonstrated that induction of phospho-Erk upon TCR
stimulation is impaired in J.CaM2 lines reconstituted with
LATY!F6,7,8 or LATY!F6 (Zhang et al. 2000; Lin and Weiss
2001). These studies demonstrated the importance of PLCc
recruitment to tyrosine 132 (#6) in LAT for TCR-induced
calcium flux and Erk activation. As demonstrated in Figure
7D, constitutive phosphorylation of both Erk and Abl kinases
in these two lines was decreased compared to wild-type Jurkat
and comparable to the levels seen in J.CaM2-LATallF and
J.CaM2 cells. Consistent with the reduced phosphorylation of
these two kinases, RAG-1 expression was increased in J.CaM2
cells reconstituted with LAT carrying only a single substitu-
tion of tyrosine residue 132 by phenylalanine (Figure 7E).
Thus, Abl, like Erk, depends upon phosphorylation of
tyrosine 132 in LAT.
Discussion
Here we have demonstrated a ligand-independent con-
stitutive signaling pathway that is functional in Jurkat T cells,
two murine thymomas, and in thymocytes. Our studies reveal
that even without TCR engagement, the signaling pathways
normally responsive to TCR stimulation are not inert. Instead
the components of these pathways deliver unique constitutive
instructions to the nucleus that maintains proper gene
expression programs. RAG gene expression is tightly regu-
lated during thymopoiesis and is expressed in at least two
waves. The tonic basal signal we characterized in this study
maintains repression of RAG gene expression and involves a
TCR-like signal transduction pathway. One arm of the
pathway requires Src family kinase activity, presence of
LAT–SLP-76, and the enzyme activities of PLCc1, PKC, PI3K,
MEK-1, and calcineurin, culminating in basal kinase activity
of Erk (Figure 8). We also identified a novel pathway that is
responsible for constitutive phosphorylation of Abl. Proper
signal transduction relies on Src family kinase activity and the
presence of tyrosine 132 in LAT and can be blocked by STI-
571 (Figure 8). We postulate that these constitutive signals
may function to repress RAG gene expression during
thymopoiesis and, as such, allow the locus to remain
accessible for later usage without inappropriate expression.
Previous reports have demonstrated the importance of
constitutive signals triggered by the antigen receptor or
coreceptors in mature lymphocytes. In order to survive, B
cells require surface expression of the BCR that generates a
basal signal independently of endogenous antigen (Lam et al.
1997). Naive peripheral T cells appear to be less dependent
on their receptors for survival (Polic et al. 2001), although
they do depend on either Lck or Fyn as well as CD4 and MHC
molecules for survival (Zamoyska et al. 2003). They also
maintain a high degree of sensitivity for foreign antigen by
having constitutive phosphorylation of TCRf (Stefanova et al.
2002). Similar signals were suggested to occur in thymocytes
(Nakayama et al. 1989; van Oers et al. 1994).
In this study, we have identified a TCR-independent and
MHC-independent signaling pathway that maintains repres-
sion of RAG gene expression in a constitutive fashion. It is
perhaps not surprising that in Jurkat cells and in thymocytes
this pathway shares components with conventional TCR
signaling. Key effector molecules for this repressive signal are
Erk and Abl kinases. One branch of this constitutive signaling
pathway involves Src family kinase activity, presumably
phosphorylation of TCRf and ZAP-70, phosphorylation of
LAT, and recruitment and activation of PLCc (Figure 8). This
results, most likely, through low-level generation of the
second messengers IP3 and DAG in constitutive activation
of Erk kinases. We also identified a novel second pathway that
results in constitutive phosphorylation and activity of Abl,
which requires phosphorylation of tyrosine residue 132 in
LAT, but not PLCc, activation. The specific requirement of
tyrosine residue 132 suggests that this pathway involves the
formation of a LAT–PLCc–Abl or LAT–Abl complex.
Recently a complex of c-Abl and PLCc1 has been reported
in growth factor receptor signaling (Plattner et al. 2003). In
agreement with these results, we observed a decrease in basal
Abl phosphorylation in PLCc1-deficient Jurkat cells (J.gam-
ma1) and normal Abl phosphorylation in PLCc1-reconsti-
tuted cells (J.gamma1.WT1; data not shown). However, basal
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activity of Erk kinases in this mutant cell line was hardly
affected, possibly because of compensation by PLCc2 in this
cell line. As a result RAG-1 expression was only moderately
increased, yet it was still repressed in J.gamma1.WT1 (data
not shown). Together these results imply an unappreciated
role for Abl kinases in thymopoiesis and TCR signaling. c-
Abl-deficient mice are born runted, are less viable, and show
signs of lymphopenia, but no stage-specific block in lympho-
cyte development (Schwartzberg et al. 1990; Tybulewicz et al.
1991). c-Abl//Arg/ mice have an embryonic lethal pheno-
type (Koleske et al. 1998). It will therefore be interesting to
assess lymphocyte development in doubly deficient mice
using a conditional deletion. Various mechanisms initiating
c-Abl activation have been suggested, such as displacement of
Figure 7. Erk and Abl Synergize to Repress
RAG-1 Expression and Require Tyrosine 132
in LAT
(A) Jurkat T cells were stimulated with 5
ng/ml PMA for 24 h to mimic a low,
constitutive MAPK signal. Intracellular
FACS staining for phospho-Erk, phos-
pho-Abl, and isotype control was per-
formed on the indicated samples.
(B) The combined effect of blocking both
Abl and MEK-1 and MEK-2 on RAG-1
expression was determined by Northern
blot analysis. Cells were treated for 24 h.
(C) RAG-1 expression levels in LAT-
deficient J.CaM2 cells treated with the
designated inhibitors compared to ve-
hicle-treated and Jurkat T cells as con-
trol.
(D) Intracellular FACS analysis using
phospho-Erk, phospho-Abl, and isotype
control antibodies on Jurkat, J.CaM2,
and J.CaM2 cells stably reconstituted
with cDNA expression vectors carrying
the indicated mutations in LAT.
(E) Consequences of a signaling defective
LAT molecule on RAG-1 mRNA levels in
the specified rest ing cel l l ines .
LATY!F6,7,8 reflects mutations in tyro-
sine residues 132, 171, and 191, whereas
LATY!F6 harbors only a single mutation
at tyrosine position 132.
DOI: 10.1371/journal.pbio.0000053.g007
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the myristate group or the SH2 or SH3 domain, all disrupting
the inactive conformation and allowing tyrosine phosphor-
ylation of residue 245 in the linker region or of 412 in the
activation loop (Hantschel et al. 2003). We hypothesize that in
this signaling pathway, binding of Abl to PLCc opens up the
inactive conformation. In addition, formation of a LAT–
PLCc–Abl complex could bring Abl in close proximity to Src
family kinases, facilitating phosphorylation of Abl by Src.
Two elegant studies have addressed the specific role of
tyrosine residue 136 of LAT, the murine equivalent of human
tyrosine 132, in vivo. Thymocytes of 2-wk-old LATY136F
knock-in mice demonstrate an incomplete block at the pre-
TCR signaling stage (Aguado et al. 2002; Sommers et al. 2002).
Paradoxically, a few weeks later the animals develop
lymphadenopathy and splenomegaly. Lymph node CD4þ cells
exhibit an activated phenotype, are of the T helper 2 type,
and are autoreactive (Aguado et al. 2002; Sommers et al.
2002). Interestingly, these peripheral cells and DP and SP
thymocytes display dramatically reduced surface TCR levels
in comparison to their wild-type counterparts. This could
reflect selection of a different repertoire due to altered
strength of signal, preferentially selecting autoreactive cells.
Alternatively, our data suggest that these thymocytes may
aberrantly express Rag genes, resulting in undesirable further
rearrangement leading to self-reacting TCRs.
Rag loci seem to remain accessible at least up to the DP
stage when surface abTCR is expressed. When ex vivo DP
thymocytes are stimulated overnight with anti-TCR antibody,
half of the cells have inactivated the Rag locus by reposition-
ing to centromeric regions (Brown et al. 1999). Incubation of
these DP cells with stroma results in the development into SP
thymocytes combined with complete centromeric reposition-
ing of the Rag locus. Permanent, heritable silencing sub-
sequently prevents further Rag expression when thymocytes
exit the thymus and become peripheral T cells. In agreement
with this model, we failed to detect induced expression of
Rag-1 in purified T cells from peripheral lymphoid organs
using our panel of inhibitors. Similarly, Yu et al. (1999) could
not observe any fluorescent activity in T cells of the RAG
reporter mice. In lymph node T cells, this cascade may very
Figure 8. Model of the Constitutive Signaling Pathway That Provides a Basal Repression of RAG Gene Transcription
Constitutive signaling in resting thymoytes and our model Jurkat T cell line represses RAG gene expression. Chemical inhibition of signaling
molecules, genetic modifications, or induced expression of genes that resulted in elevated RAG expression are summarized in the gray-shaded
boxes. The tonic signal and therefore normal expression of RAG genes rely strongly on signaling through the adapter LAT. The effects of basal
phosphorylation of LAT are twofold: (1) recruitment and activation of PLCc generates low levels of second messengers that signal through
calcium and Ras pathways, culminating in Erk kinase activity; and (2) phosphorylation of tyrosine residue 6 of LAT, likely establishing a LAT–
PLCc–Abl complex, is required for low-level kinase activity of Abl. Abl and Erk kinase activities deliver unique repressive signals to control RAG
gene expression.
DOI: 10.1371/journal.pbio.0000053.g008
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well regulate expression patterns of other genes, like those
depicted in Figure 3D, and sensitize the T cell to respond to
foreign antigens (Stefanova et al. 2002).
Repositioning of the Rag locus over time requires transient
repression, consistent with our findings here. In addition,
repression may ensure physiologic Rag levels, allowing the DP
thymocyte to test the newly assembled abTCR before addi-
tional TCRa rearrangements are started. At the moment we
can only speculate on the exact timing of the constitutive
signal during thymopoiesis. Total thymocyte populations, as
analyzed in Figure 4C, typically contain 80% DP cells. Given
the effects we observe with the various inhibitors on total
thymocytes with DP thymocytes being by far the largest
population, this is the most likely subset where basal
repression of Rag expression takes place.
Nevertheless, many components that transduce this re-
pressive signal are expressed in thymocytes well before TCR
or pre-TCR signaling occurs. It is therefore possible that Rag
genes are repressed even before the first wave of Rag
expression occurrs in CD25-positive DN thymocytes. If so, a
cytokine signal may consequently be required to release the
constitutive repression of Rag genes to allow Rag expression
and rearrangement of the TCRb chain. We are currently
adapting our intracellular FACS staining to determine
phospho-Erk and phospho-Abl in thymocyte subsets. In
addition, we are planning to study this pathway in Rag-GFP
indicator mice (Yu et al. 1999).
Our results support the notion that receptor-independent
signaling occurs in T cells and thymocytes. This tonic basal
signaling pathway utilizes many of the same signaling
components as a TCR transduction pathway triggered by
receptor engagement does. However, the activity of the
pathway is far less than is seen when the TCR is stimulated.
The basal flux of phosphorylation, second messengers, or
both in the pathway is well compensated by negative
regulators, thereby establishing a basal, steady-state tone.
Our results indicate that this basal level of activity, nonethe-
less, has significant biological consequences and functions in
T cells, as revealed here by the regulation of the RAG genes.
The existence of a constitutive, ligand-independent regula-
tory role of this pathway has implications for interpreting the
effects of mutations and chemical agents that interfere with
its activity. It is likely that such basal activity in other
signaling systems and in other cell types likewise has
significant biological functions.
Materials and Methods
Cell lines, inhibition assays, and stimulations. References to all cell
lines are cited in the text. To minimize variation in this and other
studies, we isolated a single clone by limiting dilution of Jurkat E6-1 T
cells, designated Jurkat E6-1-clone1. Clone numbers of derived cell
lines are mentioned in the text or here: J.CaM2-LAT#3 (similar results
were obtained with J.CaM2-LAT#70), J.CaM2-LATallF#11, J.CaM2-
CtoS#2, Jurkat-CD148 (L12), J.CaM2-LATY!F6,7,8#55, and J.CaM2-
LATY!F6#107. Jurkat T cells and derived cell lines were grown in
RPMI (Cellgrow, Heydon, Virginia, United States) supplemented with
5% FCS (Hyclone, South Logan, Utah, United States) and pen/strep–
glutamine (Irvine Scientific, Santa Ana, California, United States) at
densities ranging between 0.43 106 and 1.03 106 cells per milliliter.
SCB-29 cells were cultured in RPMI and DPK cells in CLICK’s
medium (Irvine Scientific), both with 10% FCS, 50 lM b-mercapto-
ethanol, and antibiotics. Thymi of 1- to 3-mo-old wild-type C57BL/6
mice or b2M//MHCII/ mice on C57BL/6 background (Taconic,
Germantown, New York, United States) were removed, and single-cell
suspensions were filtered, pelleted, and resuspended at approxi-
mately 253106 to 503106 cells per milliliter in RPMI with 20% FCS,
50 lM b-mercaptoethanol, antibiotics, 20 lM Caspase-3 inhibitor II
(Calbiochem, San Diego, California, United States), and inhibitors.
Inhibitor assays were set up in the appropriate medium. Final
inhibitors concentrations were 20 lM PP2, 10 nM rapamycin
(Calbiochem), 20 lM D609, 10 lM H89 (Sigma, St. Louis, Missouri,
United States), 1 lM Ro 31-8220 (Alexis Biochemicals, Montreal,
Quebec, Canada), 5 lM LY294002, 30 lM PD98059, 10 lMU0126 (Cell
Signaling Technology, Beverly, Massachusetts, United States), 100 ng/
ml FK506, and 10 lM STI-571 (University of California San Francisco
School of Pharmacy, San Francisco, California, United States). All
were dissolved in DMSO as a 1,000-fold stock, except STI-571, which
was dissolved in water (pH 4). Cycloheximide (Sigma) was added at 10
lg/ml and actinomycin D (ICN Biochemicals, Costa Mesa, California,
United States) at 40 lg/ml. PMA and PDBu (Sigma) were added at 25
ng/ml unless mentioned otherwise: ionomycin (Calbiochem) at 1 lM,
carbachol (ICN Biochemicals) at 100 lM. Efficacy of inhibitors and
stimulators was tested in independent assays, like phosphorylation of
Erk and NFAT luciferase assays. CD148 expression was induced by 1
lg/ml doxycyclin (Sigma), as was 48-h induction of PTEN expression.
DNA arrays. The cDNA microarrays contained 37,632 elements,
representing approximately 18,000 different genes, and were
manufactured and hybridized as previously described (Eisen and
Brown 1999; Alizadeh et al. 2000; see also http://brownlab.stanford.
edu) and were scanned using a 4000B GenePix scanner at 10 mm
resolution (Axon Instruments Inc., Union City, California, United
States). In each analysis, mRNA from a cell line was used as a template
for Cy-5-labeled cDNA synthesis. As a reference pool, RNA derived
from wild-type Jurkat cells was used to prepare Cy-3-labeled cDNA.
The Cy-5-labeled cell line cDNA and the Cy-3-labeled reference
cDNA were mixed and hybridized to microarrays. Comparison of all
experimental samples to the same reference allowed the relative
expression level of each gene to be compared across all of the
experiments. The resulting images were processed using GenePix Pro
3.0. The data were then normalized and indexed in the Stanford
Microarray Database (SMD). Expression data for some of the genes in
Figure 3 did not make the selection in Figure 1A and 1B due to high
stringency used in the experiments presented in Figure 1A and 1B.
All of the raw microarray data are available through SMD, linked via
http://microarray-pubs.stanford.edu/tonicsignal/.
RNA isolation and Northern blot analysis. RNA was isolated as
described (Chomczynski and Sacchi 1987). Total RNA (25 lg) was
separated by electrophoresis, transferred to Hybond Nþ nylon
(Amersham Biosciences, Piscataway, New Jersey, United States), and
UV cross-linked, all according to standard protocols. Hybridization
was carried out in ExpressHyb (Clontech, Palo Alto, California,
United States) with randomly labeled fragments using the Rediprime
II Random Prime Labeling System and [32P]a-dCTP (Amersham
Biosciences). For human RAG-1, mixed 400 bp and 800 bp EcoRI
cDNA fragments were used; for mouse Rag-1, a 500 bp EcoRI
fragment; for TCRa, a 350 bp HindIII–PvuII fragment encompassing
the constant region; for b-actin, a 540 bp PCR fragment (primers: 59-
gtgggccgctctaggcaccaa-39 and 59-ctctttgatgtcacgcacgatttc-39). Exposed
films were quantified avoiding image saturation using a Kodak Image
Station 440CF and Kodak ID Image Analysis Software (Eastman
Kodak Corporation, Rochester, New York, United States). Relative
expression of RAG-1 was calculated by subtracting background
intensity from all the hybridizing bands. RAG-1 intensity was
subsequently divided by b-actin intensity, and the result was adjusted
to match 100% in vehicle-treated samples.
Western blot analysis and immunopercipitations. Western blot
analysis of RIPA lysates was performed according to standard
procedures (see Lin and Weiss 2001) using antibodies following the
manufacturers’ suggestions: phospho-p44/42 MAP kinase (Thr204/
Tyr204) antibody (Cell Signaling Technology), antibodies to Erk-1
(C16) and Erk-2 (C14), and c-Abl (24-11) for immunopercipitations
and c-Abl (K12) for blotting (all Santa Cruz Biotechnology, Santa
Cruz, California, United States). c-Abl or control (using purified
mouse IgG2b; ICN Biochemicals) immunopercipitations were per-
formed on 500 ll RIPA lysates of 50 3 106 cells with 5 lg of 24-11
antibody bound to protein G–sepharose (Pharmacia, Peapack, New
Jersey, United States) in 500 ll of NP40 buffer (Lin and Weiss 2001).
Total phosphotyrosine levels were detected by 4G10 (Upstate
Biotechnology, Lake Placid, New York, United States) and visualized
using SuperSignal ECL reagent (Pierce Biotechnology, Rockford,
Illinois, United States) and a Kodak Imaging Station.
Surface and intracellular FACS analysis. To determine the
composition of thymocyte populations, cells were stained in FACS
buffer (PBS, 1% BSA) with antibodies against CD4 (conjugated to
FITC), CD8 (conjugated to tricolor) (CalTag Laboratories, Burlin-
PLoS Biology | http://biology.plosjournals.org Volume 1 | Issue 2 | Page 285
Tonic Erk and Abl Signals Repress RAG Expression
game, California, United States), CD3e (conjugated to PE) (PharMin-
gen, San Diego, California, United States) and B220, DX-5, Gr-1, Mac-
1 (eBioscience, San Diego, California, United States), and CD11b
(Pharmigen), all conjugated to APC or Cy-5 using FL-4 as a negative
gate. In addition, thymocytes negative for CD8, CD3, B220, DX-5,
CD11b, and Mac-1 were analyzed for CD25 ( (FITC) (eBioscience) and
CD44 (PE) (CalTag). Jurkat cell lines were analyzed for CD3e and
abTCR staining using anti-CD3e (clone SK7; BD Biosciences, San Jose,
California, Unied States) and anti-abTCR (clone IP26; eBioscience).
Intracellular FACS staining was performed using Fix & Perm
(CalTag) according to the manufacturer’s protocol. In short, cells
were seeded in plates at 0.4 3 106 cells per milliliter, 5 ml per well.
The next day, 43 106 cells were fixed in 100 ll of buffer A for 15 min
and twice washed in FACS buffer, and one-sixth of each sample per
staining was transferred to a concave 96-well plate. Samples were
preblocked for 10 min in buffer B containing 5% normal goat serum
(NGS) (Jackson Immunoresearch Laboratories, West Grove, Pennsyl-
vania, United States). Subsequently, cells were stained in buffer B
with 5% NGS for 1 h at 48C in the dark with 1:50 phospho-p44/42
MAP kinase (Thr204/Tyr204) antibody, 1:10 phospho-c-Abl (Tyr245)
antibody (Cell Signaling Technology), or control rabbit IgG. After two
washes in FACS buffer, cells were stained for 1 h in buffer B with 5%
NGS and 1:50 PE-conjugated AffiniPure F(ab9)2 fragment donkey
anti-rabbit IgG (Jackson Immunoresearch Laboratories), washed two
times, and analyzed.
Supporting Information
Figure 1A and 1B can interactively explored at http://microarray-
pubs.stanford.edu/tonicsignal/.
All of the raw microarray data in this paper are available through
the Stanford Microarray Database, linked via http://microarray-pubs.
stanford.edu/tonicsignal/.
Accession Numbers
Locus Link ID numbers (http://www.ncbi.nlm.nih.gov/LocusLink/) for
the loci discussed in this paper are ABCB10 (23456), c-Abl (25), Arg
(27), BIN2 (51411), Cbl (867), CD2 (914), CD3d (915), CD3e (916), CD3c
(917), CD4 (920), CD5 (921), CD6 (923), CD7 (924), CD8 (925), CD18
(281877), CD25 (3559), CD28 (940), CD44 (960), CD62L (6402), CD148
(5795), DTR (1839), Erk-2 (5594), Fyn (2534), Fyn-binding protein
(2533), Gads (9402), Grap (71520), Grb2 (2885), c-Kit (3815), Lck
(3932), MAGEA-8 (4107), MAGEA-11 (4110), MEK-1 (5604), MEK-2
(5605), MHC class II (85498), mTOR (2475), muscarinic receptor
(1128), PDGF (5159), PI3K (5295), PKA (5566), PLCc1 (5335), PTEN
(5728), RAG-1 (human) (5896), Rag-1 (mouse) (19373), RAG-2 (human)
(5897), Rag-2 (mouse) (19374), SCN2A2 (6326), SHIP (3635), SLP-76
(3937), Syk (6850), TCF7 (6932), TCRa (6955), TCRb (6957), TCRf
(919), Vav (7409), and ZAP-70 (7535).
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